自体造血干细胞移植患者带状疱疹发病率与成本数据集

数据集获取（Figshare）

• 源站标题：Herpes zoster incidence and cost in patients receiving autologous hematopoietic stem-cell transplant
• DOI：10.6084/m9.figshare.5437330.v2
• 发布日期：2018-03-02
• 文件数：3 个
• 文件总体积：60.65 KB
• 源站页面：https://tandf.figshare.com/articles/dataset/Herpes_zoster_incidence_and_cost_in_patients_receiving_autologous_hematopoietic_stem-cell_transplant/5437330

命令行下载

curl -L -o "icmo_a_1384374_sm7530.docx" "https://ndownloader.figshare.com/files/10633291"
curl -L -o "icmo_a_1384374_sm7527.docx" "https://ndownloader.figshare.com/files/10633294"
curl -L -o "icmo_a_1384374_sm2836.docx" "https://ndownloader.figshare.com/files/9394291"

文件清单

• icmo_a_1384374_sm7530.docx（15.95 KB）
• icmo_a_1384374_sm7527.docx（15.54 KB）
• icmo_a_1384374_sm2836.docx（29.17 KB）

文件总体积 60.65 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Objective: Among patients receiving autologous hematopoietic stem cell transplant (Auto-HSCT), this study estimated the incidence of herpes zoster (HZ), compared healthcare costs among patients with and without HZ, and evaluated antiviral prophylaxis (AP) use.
Research design and methods: A retrospective study was conducted using data from a large health plan to identify patients ≥18 years with ≥1 claim for an Auto-HSCT procedure during 2006–2011 (n = 2,530). Patients were followed from date of Auto-HSCT until risk-end date, defined as development of HZ, end of enrollment, death, or December 31, 2011. HZ incidence was calculated as cases observed after Auto-HSCT, divided by accrued time-at-risk in person-years (PY). AP use and duration were defined by prescription fills. One-year medical and pharmacy costs were calculated as combined health plan and patient paid amounts.
Main outcome measures: HZ incidence and healthcare costs were calculated using administrative claims data.
Results: Overall HZ incidence was 62.2/1,000 PY (95% CI = 54.3–70.9). Most (72.3%) patients were prescribed AP. During the first 90-days post-Auto-HSCT, patients without AP had increased incidence (151.6/1,000 PY, 95% CI = 88.3–242.6) compared to those prescribed AP pre- (30.9/1,000 PY, 95% CI = 11.3–67.2) or post-Auto-HSCT (33.0/1,000 PY, 95% CI = 13.3–67.9). Total adjusted mean 1-year all-cause healthcare costs were $74,875 for patients who developed HZ and $70,279 for patients who did not (difference = $4,596 (cost ratio = 1.07, 95% CI = 0.86–1.32, p = .566)).
Conclusions: HZ incidence was high, despite AP use. Mean annual healthcare costs were higher for patients with HZ, but the difference was not statistically significant. An effective vaccine against HZ could be useful in decreasing both incidence of and cost for HZ in this population.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.5437330.v2（source: https://tandf.figshare.com/articles/dataset/Herpes_zoster_incidence_and_cost_in_patients_receiving_autologous_hematopoietic_stem-cell_transplant/5437330）。